| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 2.505 | 3.879 | 3.930 | 3.714 | 3.568 | 3.476 | 4.561 | 4.966 | 4.863 |
| Total Income - EUR | - | 2.505 | 3.879 | 3.930 | 3.714 | 3.568 | 3.476 | 4.561 | 4.966 | 4.863 |
| Total Expenses - EUR | - | 2.485 | 2.549 | 2.415 | 1.870 | 1.895 | 1.117 | 387 | 1.582 | 1.882 |
| Gross Profit/Loss - EUR | - | 20 | 1.330 | 1.516 | 1.844 | 1.674 | 2.360 | 4.174 | 3.384 | 2.981 |
| Net Profit/Loss - EUR | - | -55 | 1.213 | 1.398 | 1.733 | 1.600 | 2.360 | 4.042 | 2.855 | 2.514 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Metchris Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 0 | 0 | 0 | 958 | 1.716 | 1.599 |
| Current Assets | - | 55 | 1.345 | 2.734 | 4.426 | 5.945 | 8.033 | 4.832 | 1.517 | 5.913 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 0 | 0 | 0 | 423 | 1.084 | 1.421 | 1.196 | 5.242 |
| Cash | - | 55 | 1.345 | 2.734 | 4.426 | 5.522 | 6.950 | 3.412 | 321 | 671 |
| Shareholders Funds | - | -11 | 1.203 | 2.578 | 4.261 | 5.780 | 8.012 | 5.549 | 2.983 | 2.562 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 66 | 143 | 156 | 165 | 165 | 121 | 241 | 251 | 4.949 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Metchris Medical S.r.l.